Importantly, this was associated with alleviation of SI enteropathy in CD19−/− mice (Fig. 7F and Supplementary Fig. S12), with significant reductions in leukocytosis, crypt hyperplasia, and villous blunting (Fig. 7G). Here, CD19 is linked to Abnormal intestine morphology.